These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 2515963

  • 21. Multicenter in vitro evaluation of lomefloxacin (NY-198, SC-47111), including tests against nearly 7,000 bacterial isolates and preliminary recommendations for susceptibility testing.
    Jones RN, Aldridge KE, Barry AL, Fuchs PC, Gerlach EH, Pfaller MA, Washington JA.
    Diagn Microbiol Infect Dis; 1988 Aug; 10(4):221-40. PubMed ID: 3072151
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Antimicrobial activity of lomefloxacin (NY-198, SC 47111) against bacterial strains from Venezuela.
    Torres JR.
    Diagn Microbiol Infect Dis; 1989 Aug; 12(3 Suppl):41S-43S. PubMed ID: 2791497
    [Abstract] [Full Text] [Related]

  • 25. Comparative in vitro activity of lomefloxacin (SC 47111 or NY-198) against fresh clinical bacterial isolates.
    Wright DN, Saxon B, Matsen JM.
    Diagn Microbiol Infect Dis; 1989 Aug; 12(3 Suppl):7S-11S. PubMed ID: 2791501
    [Abstract] [Full Text] [Related]

  • 26. Lomefloxacin: microbiologic assessment and unique properties.
    Mayer KH, Ellal JA.
    Am J Med; 1992 Apr 06; 92(4A):58S-62S. PubMed ID: 1316073
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Mechanism of action of lomefloxacin.
    Piddock LJ, Hall MC, Wise R.
    Antimicrob Agents Chemother; 1990 Jun 06; 34(6):1088-93. PubMed ID: 2168142
    [Abstract] [Full Text] [Related]

  • 29. Fluoroquinolone (Lomefloxacin) International Surveillance Trial: a report of 30 months of monitoring in vitro activity.
    Jones RN.
    Am J Med; 1992 Apr 06; 92(4A):52S-57S. PubMed ID: 1316072
    [Abstract] [Full Text] [Related]

  • 30. The comparative in-vitro activity of pefloxacin.
    King A, Phillips I.
    J Antimicrob Chemother; 1986 Apr 06; 17 Suppl B():1-10. PubMed ID: 2940213
    [Abstract] [Full Text] [Related]

  • 31. Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
    Ismaeel NA, Tayeb OS.
    Microbios; 1993 Apr 06; 74(300):147-54. PubMed ID: 8396196
    [Abstract] [Full Text] [Related]

  • 32. In vitro antibacterial activity of three new quinolone derivatives: rosoxacin, norfloxacin, pefloxacin.
    Husson MO, Izard D, Leclerc H.
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Dec 06; 258(2-3):283-6. PubMed ID: 6241772
    [Abstract] [Full Text] [Related]

  • 33. [Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins].
    Croize J, Le Noc P, Bryskier A, Robert J.
    Pathol Biol (Paris); 1985 Jun 06; 33(5 Pt 2):564-8. PubMed ID: 3937128
    [Abstract] [Full Text] [Related]

  • 34. [Activity of 5 fluoroquinolones on hospital Gram-negative bacilli with different sensitivities to pefloxacin].
    Aubert G, Puech C, Lucht F, Loboguerrero M, Denis M, Dorche G.
    Pathol Biol (Paris); 1989 Oct 06; 37(8):881-7. PubMed ID: 2515519
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Lomefloxacin activity against 2,813 clinical isolates: a collaborative study at three medical centers in Brazil.
    Magalhaes M, Trabulsi LR, Montelli AC.
    Diagn Microbiol Infect Dis; 1989 Oct 06; 12(3 Suppl):35S-39S. PubMed ID: 2791496
    [Abstract] [Full Text] [Related]

  • 37. Studies on the emergence of resistance to lomefloxacin in vitro.
    Kanematsu M, Greenwood D.
    Eur J Clin Microbiol Infect Dis; 1989 Aug 06; 8(8):741-5. PubMed ID: 2506046
    [Abstract] [Full Text] [Related]

  • 38. In-vitro activity of fleroxacin compared with three other quinolones.
    Bremner DA, Dickie AS, Singh KP.
    J Antimicrob Chemother; 1988 Oct 06; 22 Suppl D():19-23. PubMed ID: 3144536
    [Abstract] [Full Text] [Related]

  • 39. The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents.
    McCarter YS, Mazens-Sullivan MF, Bartlett RC.
    Chemotherapy; 1992 Oct 06; 38(5):308-18. PubMed ID: 1337507
    [Abstract] [Full Text] [Related]

  • 40. [In vitro evaluation of lomefloxacin].
    Dette GA, Knothe H.
    Arzneimittelforschung; 1989 Aug 06; 39(8):832-5. PubMed ID: 2818672
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.